Skip to main content
Premium Trial:

Request an Annual Quote

All Eyes on Australia

Though not legally binding in the US, the decision of the Australian court hearing the gene patent case similar to Myriad's might intellectually influence the US Supreme Court when it hears Myriad's appeal, according to Genomics Law Report's John Conley. Earlier this month, several plaintiffs in Sydney sued Myriad and Australian company Genetic Technologies Limited — which is licensed to perform Myriad's gene tests in Australia — on the basis that the BRCA1 and BRCA2 genes are a natural product and, therefore, not patentable. "In a technical sense, the case will have no direct effects outside of Australia," Conley says. "The general principle of international patent law is 'non-extraterritoriality' — a jaw-breaker that means simply that a patent is enforceable only within the boundaries of the country that issues it." But the Australian court system is "well-regarded," Conley adds, and its decision could intellectually influence other courts. "So the new Australian case will be, at a minimum, a chance for that country to engage in a public debate over the wisdom and legality of patenting genes," Conley says. "But in the long term it could serve to undercut the practical value of genes patents everywhere."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.